CODEXIS® We engineer enzymes to improve health… of people and the planet Q1 2021 Results May 6, 2021 Forward Looking Statements 2 • These slides and any accompanying oral presentation contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results or levels of activity, performance or achievement to diffe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-34705 ___________________________ Codexis, Inc. (Exact name of registrant as specified in its charter) ________________________ ...

CODEXIS® We engineer enzymes to improve health… of people and the planet Corporate Presentation March 2021 Forward Looking Statements 2 • These slides and any accompanying oral presentation contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results or levels of activity, performance or achievement to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34705 Codexis, Inc. (Exact name of registrant as specified in its charter) | --- | |--------------------------------------------------- ...

Codexis, Inc. (NASDAQ:CDXS) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Stephanie Marks - Investor Relations, Argot Partners John Nicols - President and Chief Executive Officer Ross Taylor - Chief Financial Officer Conference Call Participants Kyle Boucher - Cowen and Company Brandon Couillard - Jefferies & Company Lucas Baranowski - Craig-Hallum Capital Group LLC Jacob Johnson - Stephens Inc. Sean Lee - H.C. Wainwright & Co., LLC Operator Good day, and welcome to the ...

CODEXIS® We engineer enzymes to improve health… of people and the planet Q4 & FY'2020 Results February 25, 2021 Forward Looking Statements 2 • These slides and any accompanying oral presentation contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results or levels of activity, performance or achieveme ...

Corporate Presentation John Nicols, CEO & President November 2020 CODEXIS® Forward Looking Statements 2 • These slides and any accompanying oral presentation contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results or levels of activity, performance or achievement to differ materially from those ex ...

Codexis, Inc. (NASDAQ:CDXS) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Jody Cain - LHA John Nicols - President and CEO Ross Taylor - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Brandon Couillard - Jefferies Jacob Johnson - Stephens Operator Good day, and welcome to Codexis Third Quarter Financial Results Conference Call. [Operator Instructions] Please note that today's event is being recorded. At this time, I would like to turn the confe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-34705 ___________________________ Codexis, Inc. (Exact name of registrant as specified in its charter) ____________________ ...

Codexis, Inc. (NASDAQ:CDXS) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Bruce Voss - Lippert/Heilshorn & Associates John Nicols - President, CEO & Director Ross Taylor - SVP & CFO Conference Call Participants Matthew Hewitt - Craig-Hallum Brandon Couillard - Jefferies Mason Carrico - Stephens Inc. Operator Good afternoon, and welcome to the Codexis Second Quarter Financial Results Conference Call. [Operator Instructions]. I would now like to turn the conference over to Br ...